| Dec. 16, 2015 |
Approval of Main Affiliates' 2016 Total Transaction Amounts |
Approved |
4/4 |
| Approval of 2016 Total Transaction Amount with SK Biopharmaceuticals |
Approved |
| Establishment of 2016 1Q Maximum Transaction Amount with Financial Affiliate |
Approved |
| Report on 2016 Reorganization and Appointment of Executives |
Report |
| Report on Equity Investment in SoCar |
Report |
| Report on Fair Trade Voluntary Compliance Program |
Report |
| Report on Results of Execution of Board Resolutions and Committee Activities |
Report |
| Nov. 23, 2015 |
Equity Acquisition in SK Materials (former OCI Materials) |
Approved |
4/4 |
| Report on Execution Results of Board Resolutions and Results of Committee Activities
|
Report |
| Oct. 26, 2015 |
Issuance of 275th Company Bonds |
Approved |
4/4 |
| Change in Encar Branch Office |
Approved |
| Report on 2015 3Q Preliminary Results |
Report |
| Report on Execution Results of Board Resolutions and Results of Committee Activities
|
Report |
| Sep. 25, 2015 |
Establishment of 2015 4Q Maximum Transaction Amount with Financial Affiliate |
Approved |
4/4 |
| Report on 2015 DJSI Assessment Results |
Report |
| Aug. 28, 2015 |
Change in Equity Disposal Plan of U.S. Entity |
Approved |
3/4 |
| Report on 2015 DJSI Assessment Results |
Approved |
| Aug. 03, 2015 |
Appointment of Representative Director |
Approved |
3/4 |
| Appointment of Chairman |
Approved |
| Approval of Notice in lieu of General Meeting to Report Merger |
Approved |
| Change of Head Office |
Approved |
| Amendment of Regulations of the Board of Directors and Committees |
Approved |
| Appointment of Committee Members |
Approved |
| Appointment of Legal Compliance Officer |
Approved |
| Change in Maximum Aggregate Transaction Amount |
Approved |
| Report on 2015 First Half Preliminary Results |
Report |
